CUE - Cue Biopharma, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/12/2018
30/12/2017
30/12/2016
Total revenue
2,740
1,143
0
0
Cost of revenue
-
-
-
-
Gross profit
-
-
-
-
Operating expenses
Research development
27,346
28,544
18,900
5,688
Selling general and administrative
14,114
11,295
4,334
1,970
Total operating expenses
41,460
39,839
23,234
7,658
Operating income or loss
-38,721
-38,697
-23,234
-7,658
Interest expense
-
-
-
-
Total other income/expenses net
143
165
-
0
Income before tax
-38,164
-38,155
-23,234
-7,658
Income tax expense
1,238
825
-
-
Income from continuing operations
-39,403
-38,980
-23,234
-7,658
Net income
-39,403
-38,980
-23,234
-7,658
Net income available to common shareholders
-39,403
-38,980
-23,234
-7,658
Reported EPS
Basic
-
-1.94
-1.13
-0.37
Diluted
-
-1.94
-1.13
-0.37
Weighted average shares outstanding
Basic
-
20,134
20,641
20,641
Diluted
-
20,134
20,641
20,641
EBITDA
-
-37,937
-22,814
-7,456